Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

Second wave of state financial support for private hospitals

Governments across Western Europe are re-instating financial support for private hospitals involved in the second wave pandemic response. Some are treating COVID patients for the first time as hospitalisations soar above first wave numbers, but support packages are heavily-adjusted from those in spring. We talk to operators in Italy, Portugal, Germany and Switzerland and provide an update on the UK and France.

NMC beats 9-month forecast, lenders submit claims, and EY faces “£1bn+” lawsuit

In-administration global operator NMC Health's revenues are nearly 10% ahead of its business plan for 2020, while the deadline for creditors to submit claims has passed. Meanwhile, administrators Alvarez & Marsal (A&M) are reportedly preparing to sue accounting firm EY over its auditing of NMC for a reported £1bn or more.

Occupational healthcare “cuts cost of absenteeism by half”

The COVID-19 pandemic shifted the working patterns and environments of every type of workforce, resulting in big hits to free-for-service (FFS) business models and new opportunities in remote care. Panellists from Medicover, Medigold and Qualitas discussed this and how good occupational healthcare can reduce the costs of absenteeism by half, at last week's HBI Big Picture Seminar.

UK care specialist Heathcotes sells

Care services provider Envivo Group has bought the opco of Heathcotes, while social impact investor Civitas Investment Management (CIM) has acquired the real estate.

FDA approves first home COVID-19 test

The US Food and Drug Administration (FDA) has approved its first COVID-19 test where patients can both take the sample and receive results at home.

Diaverum to IPO in Stockholm as Saudi JV buyout boosts EBITA

Global renal care group Diaverum's upcoming Stockholm IPO has 'strong international and Swedish investor interest', CEO Dimitris Moulavasilis tells HBI, as the market reaches historic highs. We talk expansion and diversification plans and 2020 performance. 

COVID vaccine: Shot in the arm the markets needed?

Pfizer shares rocketed 15% on Monday with news of a vaccine that's more than 90% effective. But lab and telehealth shares plummeted upon the announcement while hospitals, care homes and outpatient groups recouped some of their YTD losses. HBI explores what a vaccine might mean across the five sub-sectors.

CVC “frontrunner to buy Eugin”

HBI hears that CVC is frontrunner to buy international IVF chain Eugin as parent company NMC Health's administrators Alvarez and Marsal looks to complete a lender-led sale of the group by Spring 2021.

Find Us